Indo-MIM

Founded in 1996, Indo-MIM has evolved into a global leader in the precision engineering space. The company specializes in Metal Injection Molding (MIM), a sophisticated process that allows for the creation of complex metal parts with high precision and minimal waste. Over nearly three decades, the firm has expanded its technical capabilities to include investment casting, precision machining, ceramic injection molding, and 3D metal printing.

The business model is diversified across multiple high-growth industries. Its product portfolio is extensive, featuring everything from fuel systems and powertrains for the automotive sector to triggers, hammers, and sights for the defense industry, as well as specialized components for medical and aerospace applications. This diversification reduces dependency on any single industrial cycle.

Indo-MIM maintains a significant global footprint to serve its more than 1,000 customers worldwide. The company operates 15 manufacturing facilities spread across India, the United States, the United Kingdom, and Mexico. To support its international client base, it has established strategic sales offices in China, Germany, and the United States.

In terms of operational scale, the company's product range is vast, having manufactured over 6,400 distinct products as of FY25. This scale demonstrates a deep technical competence in mold design, tooling, and finishing. The company is led by promoters including Green Meadows Investments Ltd., Krishna Chivukula, Krishna Chivukula Jr, Raj Chivukula, and Jagadamba Chandrasekhar.

The Indo-MIM IPO is a Mainboard issue aiming to raise approximately ₹3,811.21 Crores. The issue structure consists of a fresh issue of ₹499.10 Crores and a significant Offer for Sale (OFS) of 6,82,91,022 equity shares. The price band is set between ₹461 and ₹485 per share, with a minimum retail lot size of 30 shares requiring an investment of ₹14,550. The IPO is scheduled to open on July 23, 2026, and close on July 27, 2026, with listing on the BSE and NSE on July 30, 2026.

Proceeds from the fresh issue are primarily earmarked for the repayment or prepayment of outstanding borrowings, amounting to ₹400.00 Crores, which indicates a strategy to deleverage the balance sheet and improve financial agility.

Financial performance shows a strong upward trajectory. Revenue grew from ₹2,900.38 Crores in FY24 to ₹3,373.97 Crores in FY25, and jumped significantly to ₹4,320.70 Crores in FY2026. Profitability has also remained robust, with PAT increasing from ₹283.73 Crores in FY24 to ₹533.54 Crores in FY26, reflecting strong operational efficiency and market demand.

From a valuation perspective, the company reports an EPS of ₹11.06 (Basic) for FY26. While a direct P/E comparison is limited, the company demonstrates high efficiency with an ROE of 21.26% and ROCE of 26.60%. The primary investment strength lies in its global manufacturing footprint and specialized MIM technology.

However, risks include the heavy weight of the OFS, as nearly 87% of the issue is promoter offloading rather than capital infusion into the business. Additionally, the large issue size may require significant market liquidity to sustain a high listing premium. Investors should weigh the impressive growth and margins against the structural nature of the offer.